latest news releases from the newsroom
TalkingStocks.com Issues Comprehensive Profile Report Update on Biophan Technologies
DALLAS, Dec. 13, 2004 (PRIMEZONE) -- TalkingStocks.com issued an update to our Profile Report on Biophan Technologies, Inc. (OTCBB:BIPH). The Profile Report is authored by Jeff Bishop, Senior Investment Analyst for TalkingStocks.com. Discussed in the Profile Report is the importance of MRI technology, the limitations with MRI Technology for patients with implants, and the newly issued "Anti-Antenna" patent which gives Biophan market dominance in MRI safety.
TalkingStocks.com Issues Profile Report on Markland Technologies, Inc.
DALLAS, Dec. 13, 2004 (PRIMEZONE) -- TalkingStocks.com issues a comprehensive Profile Report on Markland Technologies, Inc. (OTCBB:MRKL). The Profile Report is authored by Jeff Bishop, Senior Investment Analyst for TalkingStocks.com. Discussed in the Profile Report are the company's four primary business divisions. These are, first, sensor systems for military and intelligence application; second, chemical detectors; third, border security systems; and, fourth, advanced technologies. Also discussed is the business strategy for the company, large order flows, and an industry overview.
ProAct IT Group
New CEO and Group Manager at PROACT IT GROUP AB (publ)
STOCKHOLM, Sweden, Dec. 13, 2004 (PRIMEZONE) -- Olof Sand, Divisional Manager of Business Consulting at AcandoFrontec has today been appointed CEO and Group Manager of Proact IT Group AB. He will take up his post by 1 February 2005 at the latest. Olof Sand is one of the founders of Acando, which merged with Frontec to form AcandoFrontec. His previous career has included management and change assignments at companies such as ABB and Tele2.
AB Volvo ranked high on Dow Jones Sustainability Indexes
GOTEBORG, Sweden, Dec. 13, 2004 (PRIMEZONE) -- AB Volvo hits a new top rate on the Dow Jones Sustainability World Index (DJSI World) and is ranked high on the Pan European Sustainability Benchmark (DJSI STOXX), which includes companies that are judged to actively seek long-term sustainable development.
Maxim Pharmaceuticals Reports Fiscal 2004 Financial Results
STOCKHOLM, Sweden and SAN DIEGO, Dec. 13, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals, Inc. (Nasdaq:MAXM) (SSE:MAXM) today reported financial results for the fourth quarter and the year ended September 30, 2004. The net loss applicable to common stock for the fourth quarter ended September 30, 2004 totaled $14.5 million, or $0.51 per share, compared to a net loss applicable to common stock of $12.8 million, or $0.54 per share, for the same period of the prior year. The net loss applicable to common stock for the year ended September 30, 2004, totaled $45.0 million, or $1.59 per share compared to a net loss applicable to common stock of $45.5 million or $1.94 per share, for the prior year.
Trintech Group Plc
SunGard Treasury Systems and Trintech Expand Agreement
DUBLIN, Ireland, DALLAS and CALABASAS, Calif., Dec. 13, 2004 (PRIMEZONE) -- SunGard Treasury Systems, an operating group of SunGard (NYSE:SDS), and Trintech (Nasdaq:TTPA) (Prime Standard:TTP), a leading provider of transaction reconciliation and payment infrastructure solutions, today announced an expanded agreement that enables SunGard Treasury Systems to offer Trintech's Bank Fee Analysis system to its customers
Provalis plc Signs Vaccine Option Agreement with Aventis Pasteur
DEESIDE, Flintshire, U.K., Dec. 13, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, today announces that it has signed an option agreement with Aventis Pasteur, the vaccines business of the sanofi-aventis Group, for the development of vaccine candidates to prevent streptococcus pneumoniae infection.